Mirion
MIR
16.07
-1.11
-6.46%
Mirion
US · MIR
#2362 by market cap
Listed 1970
16.07
-1.11
-6.46%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions increased by 3 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.8 percentage points.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 111.95% -0.81pp
- Institutions
- 432 +3
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund86.67%
Hedge Fund14.77%
Sovereign Wealth Fund4.30%
Public Company3.71%
Individual/Insider3.60%
Government Pension Fund1.24%
Private Company0.58%
Insurance Company0.43%
Family Office/Trust0.16%
Top holders as of 2026-09-30
BlackRock
16.03% · 38.44M sh
Vanguard Portfolio Management, LLC
7.48% · 17.93M sh
T. Rowe Price Group, Inc.
6.14% · 14.71M sh
Vanguard Capital Management, LLC
4.42% · 10.59M sh
Kuwait Investment Authority
4.24% · 10.17M sh
State Street Global Advisors
4.13% · 9.89M sh
Alyeska Investment Group, L.P.
3.98% · 9.53M sh
Omega Advisors, Inc.
3.50% · 8.38M sh
Goldman Sachs Asset Management, L.P.
3.13% · 7.50M sh
FMR
3.01% · 7.32M sh
Geode Capital Management, LLC
2.54% · 6.09M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 21 buys · 29 sells
| Name | Role | Stake |
|---|---|---|
| Lawrence Kingsley | Independent Director | 1.49% |
| Thomas Logan | Founder, Medical Group President, CEO & Chairman | 1.47% |
| Brian Schopfer | CFO & Medical Group President | 0.38% |
| Loic Eloy | Group President of Nuclear & Safety Technologies | 0.04% |
| Emmanuelle Lee | Executive VP, Chief Legal Officer, Chief Compliance Officer & Secretary | 0.03% |
| Steven Etzel | Independent Director | 0.03% |
| Jody Markopoulos | Independent Director | 0.03% |
| John Kuo | Independent Director | 0.03% |
| Kenneth Bockhorst | Lead Independent Director | 0.03% |
| Robert Cascella | Independent Director | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Lawrence Kingsley | Independent Director | Other Acquisition | +1,333 | $14.34 |
| 2026-09-29 | Jody Markopoulos | Independent Director | Other Acquisition | +1,333 | $14.34 |
| 2026-09-01 | Brian Schopfer | CFO & Medical Group President | Open Market Acquisition | +20,000 | $15.60 |
| 2026-06-29 | Lawrence Kingsley | Independent Director | Other Acquisition | +1,095 | $17.46 |
| 2026-05-12 | Robert Cascella | Independent Director | Other Acquisition | +7,383 | -- |
| 2026-05-12 | John Kuo | Independent Director | Other Acquisition | +7,383 | -- |
| 2026-05-12 | Lawrence Kingsley | Independent Director | Other Acquisition | +7,383 | -- |
| 2026-05-12 | Steven Etzel | Independent Director | Other Acquisition | +7,383 | -- |
| 2026-05-12 | Jody Markopoulos | Independent Director | Other Acquisition | +7,383 | -- |
| 2026-05-12 | Sheila Rege | Independent Director | Other Acquisition | +7,383 | -- |
| 2026-05-12 | Kenneth Bockhorst | Lead Independent Director | Other Acquisition | +7,383 | -- |
| 2026-05-06 | Christopher Moore | Chief Accounting Officer | Open Market Disposition | -8,400 | $19.64 |
| 2026-05-05 | Thomas Logan | Founder, Medical Group President, CEO & Chairman | Other Disposition | -311,851 | -- |
| 2026-03-31 | Emmanuelle Lee | Executive VP, Chief Legal Officer, Chief Compliance Officer & Secretary | Sale to Issuer | -4,680 | $18.59 |
| 2026-03-31 | Thomas Logan | Founder, Medical Group President, CEO & Chairman | Sale to Issuer | -22,614 | $18.59 |
| 2026-03-31 | Brian Schopfer | CFO & Medical Group President | Sale to Issuer | -7,377 | $18.59 |
| 2026-03-31 | Alison Ulrich | Chief Human Resources Officer | Sale to Issuer | -2,053 | $18.59 |
| 2026-03-31 | Christopher Moore | Chief Accounting Officer | Sale to Issuer | -1,903 | $18.59 |
| 2026-03-30 | Lawrence Kingsley | Independent Director | Other Acquisition | +1,104 | $17.32 |
| 2026-03-01 | Thomas Logan | Founder, Medical Group President, CEO & Chairman | Sale to Issuer | -147,834 | $21.61 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Mirion discussion 0 comments